Trials & R&D · first seen 10h ago, updated 10h ago
ELEPHAS BIOSCIENCES AND TES PHARMA COLLABORATE TO ADVANCE TRANSLATIONAL RESEARCH FOR LUNG CANCER THERAPY
Tes Pharma Will Use the elive™ Platform to Functionally Evaluate Response to TES-4207 in Live Tumor Fragments as a Monotherapy and in Combination With Immune Checkpoint Inhibitors MADISON, Wis., Sept. 24, 2026 /PRNewswire/ -- Elephas Biosci…
Summary from PR Newswire - Clinical Trials.
Coverage 1 article · 1 outlet
-
PR Newswire - Clinical TrialsELEPHAS BIOSCIENCES AND TES PHARMA COLLABORATE TO ADVANCE TRANSLATIONAL RESEARCH FOR LUNG CANCER THERAPY